Emmanuel J. Simons
Chief Executive Officer bij AKOUOS
Actieve functies van Emmanuel J. Simons
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKOUOS | Chief Executive Officer | 01-01-2016 | - |
| Founder | 01-01-2016 | - |
Loopbaan van Emmanuel J. Simons
Opleiding van Emmanuel J. Simons
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Executive Officer | 1 |
| Founder | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Emmanuel J. Simons
- Ervaring
